Magnetar Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,114,010
| Closed | -$205K | – | 1712 |
|
|
2021
Q2 | $205K | Sell |
1,114,010
-175,838
| -14% | -$32.3K | 1.94% | 2 |
|
|
2021
Q1 | $197M | Buy |
1,289,848
+109,195
| +9% | +$16.7M | 1.9% | 7 |
|
|
2020
Q4 | $184M | Buy |
+1,180,653
| New | +$184M | 2.61% | 6 |
|
|
2019
Q4 | – | Sell |
-118,049
| Closed | -$11.6M | – | 676 |
|
|
2019
Q3 | $11.6M | Buy |
118,049
+63,449
| +116% | +$6.21M | 0.29% | 64 |
|
|
2019
Q2 | $7.15M | Buy |
54,600
+35,600
| +187% | +$4.66M | 0.14% | 78 |
|
|
2019
Q1 | $2.57M | Buy |
19,000
+15,227
| +404% | +$2.06M | 0.07% | 89 |
|
|
2018
Q4 | $367K | Buy |
+3,773
| New | +$367K | 0.01% | 170 |
|
|
2017
Q4 | – | Sell |
-3,584
| Closed | -$503K | – | 925 |
|
|
2017
Q3 | $503K | Buy |
+3,584
| New | +$503K | 0.01% | 425 |
|
|
2017
Q2 | – | Sell |
-2,823
| Closed | -$342K | – | 985 |
|
|
2017
Q1 | $342K | Buy |
+2,823
| New | +$342K | ﹤0.01% | 522 |
|
|
2016
Q4 | – | Sell |
-11,595
| Closed | -$1.42M | – | 421 |
|
|
2016
Q3 | $1.42M | Buy |
11,595
+2,424
| +26% | +$297K | 0.02% | 201 |
|
|
2016
Q2 | $1.07M | Buy |
+9,171
| New | +$1.07M | 0.02% | 148 |
|